Reuters - Eli Lilly and Co said it is withdrawing its sepsis drug Xigris from all markets after it failed to help patients live longer in a clinical trial.
You are here:
Health 
Diseases & Conditions Lilly withdraws sepsis drug Xigris from market
(Reuters)
Diseases & Conditions Lilly withdraws sepsis drug Xigris from market
(Reuters)
